Identification of Barriers Preventing Biosimiliar Oncology Medication Adoption
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58111533
Abstract: (1) Background: A biosimilar is a biologic medical product that has been approved by the United States Food and Federal Drug Administration (FDA) and is an almost identical copy of an original biologic product yet… read more here.
Keywords: oncology; oncology medication; identification barriers; barriers preventing ... See more keywords